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1. Introduction
A wave is usually defined as an oscillating function that is localized in both time and frequency.
A wavelet is a “small wave”, which has its energy concentrated in time providing a tool for
the analysis of transient, non-stationary, or time-varying phenomena [1, 2]. Wavelets have the
ability to allow simultaneous time and frequency analysis via a flexible mathematical foun‐
dation. Wavelets are well suited to the analysis of transient signals in particular. The localizing
property of wavelets allows a wavelet expansion of a transient component on an orthogonal
basis to be modelled using a small number of wavelet coefficients using a low pass filter [3].
This wavelet paradigm has been applied in a wide range of fields, such as signal processing,
data compression and image analysis [4 -10].
Typically agitation-sedation cycling in critically ill patients involves oscillations between states
of agitation and over-sedation, which is detrimental to patient health, and increases hospital
length of stay [11-14]. The goal of the research specifically in reference [14] was to develop a
physiologically representative model that captures the fundamental dynamics of the agitation-
sedation system. The resulting model can serve as a platform to develop and test semi-
automated sedation management controllers that offer the potential of improved agitation
management and reduce length of stay in the intensive care unit (ICU). A minimal differential
equation model to predict or simulate each patient’s agitation-sedation status over time was
presented in [14] for 37 ICU patients, and was shown to capture patient A-S dynamics. Current
© 2013 Kang et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
agitation management methods rely on subjective agitation assessment and an appropriate
sedation input response from recorded at bedside agitation scales [15, - 19]. The carers then
select an appropriate infusion rate based upon their evaluation of these scales, their experience
and intuition [20]. This process is depicted in Figure 1 (see [14]). Recently a more refined A-S
model, which utilised kernel regression with an Epanechnikov kernel and better captured the
fundamental agitation-sedation (A-S) dynamics was formulated [12, 13].
A secondary aim of this chapter is to test the feasibility of wavelet statistics to help distinguish
between patients whose simulated A-S profiles were “close” to their mean profile versus those
for whom this was not the case (i.e. their simulated profiles are not “close” to their actual
recorded profiles). This chapter builds on a preliminary study [21] to assess wavelet signatures
for modelling ICU agitation-sedation profiles, so as to, as in this chapter, evaluate “closeness”
or “discrimination” of simulated versus actual A-S profiles with respect to wavelet scales - as
recently analysed using DWT and wavelet correlation methods in [29] (see also [22]-[24]). The
recent work of Kang et al. [29] investigated the use of DWT signatures and statistics on the
simulated profiles derived in [12] and [13], to test for commonality across patients, in terms of
wavelet (cross) correlations. Another earlier application of this approach was the study of
historical Australian flowering time series [22], where it was established that wavelets add
credibility to the use of phenological records to detect climate change. This study was also
recently expanded and reported by Hudson et al. [23, 24] (see also references [25-28]).
Figure 1. Diagram of the feedback loop employing nursing staff’s feedback of subjectively assessed patient agitation
through the infusion controller (diagram is sourced from [14]).
The density function is very important in statistics and data analysis. A variety of approaches
to density estimation exist. Indeed the density estimation problem has a long history and many
solutions [30, 31, 32]. A large body of existing literature on nonparametric statistics is devoted
to the theory and practice of density estimation [32-36]. The local character of wavelet functions
is the basis for their inherent advantage over projection estimators – specifically that wavelets
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are straightforward and well localized in both space and frequency. The relevant estimation
methods belong to the class of so-called projection estimators, as introduced by [36] or their
non-linear modifications. Section 3 traces, in brief, the development of some basic methods
used in density estimation. We then link these and apply wavelet methods for (density)
function estimation to the ICU data of [29].
In this chapter the density is estimated using wavelet shrinkage methods, as based on Bayesian
methods. Specifically the minimax estimator is used to obtain a patient specific wavelet
tracking coverage index (WTCI). All values of the WTCI are obtained using Bayesian wavelet
thresholding, and are shown to differentiate between poor versus good tracking. A Bayesian
approach is also suggested in this chapter by which to assess a parametric A-S model – this by
constructing a wavelet probability band (WPB) for the proposed model and then checking how
much the nonparametric regression curve lies within the band. The wavelet probability band
(WPB) is shown to provide a useful tool to measure the comparability between the patient’s
simulated and recorded profiles. Moreover, the density profile is then successfully used to
define and compute two numerical measures, namely the average normalized wavelet density
(ANWD) and relative average normalized wavelet density (RANWD) – both measures of
agreement between the recorded infusion rate and simulated infusion rate. Our WPB method
is shown to be a good tool for detecting regions where the simulated infusion rate (model)
performs poorly, thus providing ways to help improve and distil the deterministic A-S model.
The so-called Wavelet Time Coverage Index (WTCI) developed is analogous to the metrics
based on a kernel based probability band of [13, 14]. The research in [29] and that formulated
in this chapter have successfully developed novel quantitative measures based on wavelets
for the analysis of A-S dynamics.
2. Density estimation using wavelet smoothing
In order to apply wavelets to various function estimation problems, it is useful to examine
some of the existing techniques in use. This provides a useful lead in to a discussion of wavelet
methods for (density) function estimation, since typical techniques can be modified in a
straightforward manner for use in a wavelets approach and for a subsequent wavelets based
analysis.
In exploratory data analysis it is important to have an idea of the shape of the data distribution,
whereby interesting features become evident. For example, in describing the shape of the data,
by a histogram, we easily obtain an overall feel for the data. Specialised versions of histograms
that can be constructed using the Haar wavelet basis are now discussed in brief. Important
theoretical properties of this estimator are discussed further in [37]. The Haar wavelet
approach and histogram leads naturally to density estimators with smoother wavelet bases
and lend themselves to histogram estimators, as we require.
Given the Haar scaling function, as on the left hand side of Equation (1), and then applying
the usual dilation and translation gives,
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We can then count the number of data points that lie within a particular interval, say,
2- jk , 2- j(k + 1)) using the quantity 2- j/2∑
i=1
n ϕ j ,k (ti).
Now for any t∈ R and j∈Z,
( )- -2 2 2 2 1 ,j j j jt t té ù £ < +ë û (2)
where [t] denotes the greatest integer function of t, the number of data points that lie in the
same interval as any real number t can be computed by
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The histogram density estimator with origin 0 and bins of width 2-J  is given by
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This estimator can be regarded as being the best estimator of the density f on the approximation
space VJ, where VJ is defined as length N/2J vector scaling coefficients associated with averages
on a scale of length 2J = 2λJ. Construction of histograms using the Haar basis, then leads to more
general wavelet density estimators. The decomposition algorithm can be applied to Equation
(1) and the resultant histogram can be written in terms of the Haar wavelets as follows:
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The Haar-based histograms are given in Figure 2 (for level 1, 2, 3, and 4) for Patient 12 and
Patient 18, with the simulated infusion rate (light) and the recorded infusion rate (dark) shown.
Figure 2 shows a similar distribution between each patient’s recorded and simulated infusion
rates - skewed right for both patients (P12 and P18). Correspondingly Figure 3 presents the
simulated data and recorded A-S data of Patient 2 and Patient 27. Each patient’s simulated and
recorded series are clearly from a differing distribution type to each other for these poor
trackers (P2 and P27) (Figure 3). Figures 2-3 are clearly more informative than the histogram
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where the former density estimates are based on the Haar wavelet basis. These graphical
comparisons allow us to visualize differences in the distribution between the poor and good
tracking patients in ICU.
Estimating density functions using smooth wavelets can be performed in the same way for
any orthogonal series. This estimation procedure, which is a natural application of wavelets,
results from a straightforward extension of the Haar-based histogram approach [30]. The same
approach used to estimate a density in terms of the Haar basis above can thus also be used
with smooth wavelet bases, as we now illustrate.
Let ϕ and ψ be an orthogonal scaling function and mother wavelet pair that generates a series
of approximating spaces {V j} j∈ℤ., then f (x), which is a square integrable density function, is
( ) ( ) ( )0 0
0
, , , , ,j k j k j k j k
k j j k
f x c x d xf y
>
= +å åå (6)
where j0 represents a coarse level of approximation. Haar coefficients are estimated using
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From Equations (7) and (8) above, the wavelet estimator for f at level J ≥ j0 is given by
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The smoothing parameter in Equation (9) is the index J of the highest level considered. Smooth
wavelet-based density estimates are plotted in Figure 4 for levels 4, 6, and 8, using Patient 4’s
simulated infusion and recorded infusion rate data (via Daub (4) which denotes the Daubechies
wavelet filter of length 4). We sampled 2048 (=210) data points without loss of any generality
from the original data of Patient 4.
Figure 5 shows Patient 29’s smooth wavelet-based density estimates (using Daub (4)). Figures
4 and 5 indicate that Patent 4 (P4) is potentially a poor tracker and Patient 29 (P29) a good
tracker, given that the original and wavelet smooth densities are similar in P29, but not for P4.
Note that when level J is increased, abrupt jumps disappear but can also lead to over-smooth‐
ing and loss of information.
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 Figure 2. Haar-based histogram of the simulated series (light) and recorded empirical A-S series (dark) for varying res‐
olution levels for two “good trackers”: Patient 12 (left side, 4 plots) and Patient 18 (right side, 4 plots).
 
Figure 3. Haar-based histogram of the simulated series (light) and recorded series (dark) for varying resolution levels
for two “poor trackers”: Patients 27 (right side, 4 plots) and 2 (left side, 4 plots).
To quantify the relationship between the two variables (xi,  yi), we can employ the standard
regression model as follows,
( ) ,  1,..., ,i i if x i ne= + =y (10)
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where the εi’s are independent and identically distributed N(0,  σ 2) random variables. It will
be assumed that the design points (x1, ..., xn) are equally spaced, and, without further loss of
generality, that they lie on the unit interval: xi =1 / n,  i =1, ..., n. Our approach constitutes
projecting the raw estimator f onto the approximating space VJ, for any choice of the smoothing
parameter J, which represents a linear estimation approach. In contrast to this, the approach
reference [38] offers a non-linear wavelet based approach to this problem of nonparametric
regression. The approach in [38] begins with computing the DWT of the data yi,  by generating
a new data set of empirical wavelet coefficients with which to represent the underlying
regression function f.
The estimation procedure in [38] has three main steps as follows: First, transform the data yi
to the wavelet domain by applying a DWT. If d is the DWT of f, and d ′ = c ′0,0, d ′0,0, ..., d ′ J −1,2 J −1 T
the vector of empirical coefficients, we then have a sequence of wavelet coefficients d ′ =d+ε ′,
where ε ′ is a vector of n independent N(0, σ 2). In the second step, the true coefficients d are
estimated by applying the thresholding rule to the empirical coefficients d ′ to obtain estimates,
d˜ . Finally, the sampled function values f are estimated by applying the inverse DWT (IDWT)
to obtain f˜ =W T d˜ , where W T  is the transpose of an orthonormal n×n matrix. We can then
represent the DWT as the sum
( ) ( ) ( )2 10,0 , ,
0 0
jJ
j k j k
j k
f x c x d xf y-
= =
= +åå% %% (11)
Figure 4. Smooth wavelet-based density estimates for P4’s recorded data (light) and simulated data (dark) using the
Daubechies wavelet (Daub4) with sub- sample N=2048 and for different choices of J.
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Figure 5. Smooth wavelet-based density estimates for P29’s recorded (light) and simulated data (dark) using the Dau‐
bechies wavelet (Daub4) with N=2048 and for different choices of J.
This procedure, as formulated in [38], is schematised below:
 






Wavelet Estimate:  
( )  Þ Jf x f  
Scheme 1. Schema of DWT procedural steps.
A technique for selective wavelet reconstruction similar to this general approach was proposed
in [39] in a study to remove random noise from magnetic resonance images. The technique is
further developed from a statistical point of view in [38] by framing selective wavelet recon‐
struction as a problem in multivariate normal decision theory. From [38] estimating an
unknown function involves including only coefficients larger than some specific threshold
value. A large coefficient is taken to mean that it is large in absolute value. Choosing an
excessively large threshold will make it difficult for a coefficient to be judged significant and
be included in the reconstruction, resulting in over smoothing. On the other hand, a very small
threshold allows many coefficients to be included in the reconstruction, resulting in under-
smoothed estimates.
Two methods of global wavelet thresholding were proposed in [38], namely the universal
threshold and the minimax threshold method. The wavelet assumption of a dyadic length of
the time series is not always true. A natural approach would then be to pre-condition the
original data set, so as to obtain a set of values of length 2J for some positive integer J. The
resulting pre-conditioned data is then plugged directly into any standard DWT. We observed
that most of the 37 ICU patient data is not to the power of two. One obvious remedy was to
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pad the series with values and increase its length to the next power of two. There are several
choices for the value of these padded coefficients. The approach adopted in this chapter was
to pad with zeros so as to increase the size of the data set to the next larger power of two, or
some other higher composite number, and then apply the DWT. The minimax estimator
approach with soft thresholding, as applied to the simulated infusion profile of Patient 2, for
example, yielded the profile in Figure 6.
3. New non Bayesian wavelet based metrics for tracking (WTCI, ANWD,
RANWD)
Based on the development of density estimation via wavelet smoothing discussed in section
2, specifically equations (9) to (11), we now derive three new wavelet based, but non Bayesian
metrics for tracking, namely the Wavelet Time Coverage Index (WTCI) (section 3.1), the
Average Normalized Wavelet Density (ANWD) and the Relative Average Normalized
Wavelet Density (RANWD) (section 3.2).
3.1. Numerical approach 1: Wavelet Time Coverage Index (WTCI)
The most commonly used criterion to obtain a successful wavelet estimator of the signal y˜ in
estimating y is the mean square error (MSE) [40]. In this chapter we devise a variant based on
the development of the smoothed recorded infusion. This then lays the foundation for the
development of our Wavelet Time Coverage Index (WTCI). The WTCI is a quantitative
parameter indicating how well the patient’s simulated infusion represents their average
recorded infusion profile over the entire time series. Our approach uses wavelet coefficients
on a scale by scale basis.
The WTCI is defined as follows:
, ,,
,,









where d˜ j ,k  is given in Equation (11) and d j ,k  is the DWT of f in Equation (10). A WTCI of 100%
represents perfect tracking, which arises when the DE simulated infusion profile is identical
to that of the wavelet smoothed infusion profile.
Figure 7 presents the box and whisker plot for values of the WTCI from bootstrap [56]
realizations (per patient). Each box and whisker [57] in Figure 7 displays two main components
of information. First, the median represents a measure of how well the agitation-sedation
simulation models the recorded infusion profile on average. Second, the spread of the box and
whisper provides an indication of how reliable that particular WTCI median is per patient.
Further details regarding interpretation of the WTCI are given in section 5.1.
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3.2. Numerical approach 2: Average Normalized Wavelet Density (ANWD) and the Relative
Average Normalized Wavelet Density (RANWD)
We now propose wavelet analogues of the AND and RAND diagnostics developed in [12] and
[13]. The density profile is used to compute the numerical measures of ANWD and RANWD,
so that objective comparisons of model performance can be made across different patients. The
ANWD value for the simulated infusion rates is the average of these normalized density values
over all time points for a given patient. Similarly, the RANWD value for the smoothed infusion
rate is obtained by superimposing the smoothed values by using the first cumulant from a
normal posterior distribution onto the same density profile, after which RANWD can be
readily computed.
Let yt = {y1,y2, ..., yn} be the output data produced by a proposed model. These are often called
the simulated data. Define the average normalized wavelet density (ANWD) of yt  as






= å % %yy (13)
where max( f˜ t)denotes the maximum value of the wavelet density function f˜ t , which is
estimated by wavelet smoothing via Equation (9) at time t. Thus, ANWD is an average of
Figure 6. Minimax estimator applied to Patient 2’s simulated profile. The thick line represents the wavelet threshold
estimator of the simulated infusion rate and the thin line that of the recorded infusion data. A soft thresholding rule
was used to obtain all estimates.
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normalized densities, where each component in the sum is the value of f˜ t  at yt  normalized by
max( f˜ t). At time t the normalized wavelet density equals 1 when X t  coincides with the point
where f˜ t  is maximum. An infusion profile that coincides with the maximum wavelet density
at every time point would therefore have ANWD equal to 1. Whereas the value of ANWD for
an infusion profile distant from the high-density regions would approach 0. Finally, ANWD
(y) is calibrated using the ANWD from the wavelet smoothed recorded infusion data, denoted






RANWD indicates the value of ANWD (y) relative to a typical realisation in the form of y˜ from
the density profile. Therefore, the RANWD statistic estimates how probabilistically alike the
model outputs are to the smoothed data, and hence the degree of comparability between the
model (simulated) and the actual (recorded) data. A RANWD of 0.6 implies that the model
outputs are 60% similar, on average, to the wavelet smoothed data. Greater similarity means
higher values of RANWD for the given patient under investigation.
4. Wavelet thresholding via Bayesian methods
Bayesian wavelet shrinkage methods are discussed in section 4.1, and are subsequently used
to develop a novel 90% wavelet probability band (WPB 90%) per patient (section 4.2). A 90%
wavelet probability band is constructed for each of the 37 patient profiles, and the time and
Figure 7. Box and whisker plot of the WTCI index for each of the 37 patients.
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duration of any deviations from the wavelet probability band is recorded. A WPB 90% value
of 70% implies that for at least 70% (time under ICU observation), the estimated mean value
of the recorded infusion rate, for a given patient, lies within the 90% confidence interval of its
wavelet probability band. For illustration, we refer the reader to Figure 8 which shows the
WPB 90% curves for 4 patients: two good trackers (Patients 8 and 25) and two poor trackers
(Patients 9 and 34).
4.1. Brief mathematical background
Recall the regression equation (Equation (10)) for an observed data vector y1, y2,...,yn satisfying
yi = f (xi) + εi, i =1, ..., n,
where the εi’s are independent and identically distributed N(0, σ 2) random variables, assum‐
ing that (x1, ..., xn) are fixed points.
We now consider a method to approximate the posterior distribution of each f (xi), using the
same prior utilised by the BayesThresh method of [41] and [42]. Posterior probability intervals
of any nominal coverage probability can be calculated accordingly. For Haar wavelets, the scaling
function and mother wavelet are ϕ(t)= I (0≤ t <1) and ψ(t)= I (0≤ t <1 / 2)− I (1 / 2≤ t <1), respec‐
tively, where I (⋅ ) is the indicator function. Clearly the square of the Haar wavelet is just the Haar
scaling function, ψ j ,k2 (t)=2 j/2ϕ j ,k (t),  ψ j ,k3 (t)=2 jψ j ,k (t); ψ 3(t)=ψ(t) and ψ 2(t)=ψ 4(t)=ϕ(t) and
ψ j ,k4 (t)=23 j/2ϕ j ,k (t). All these terms can be included in a modified version of the IDWT algo‐
rithm which incorporates scaling function coefficients. By the development in [43] we approxi‐
mate a general wavelet ψ j0,0r , (0≤ j0≤ J −m), by
( )0 0 0,0 , ,~rj j m l j m lt e ty f- -å (15)
for r = 2, 3, 4, where m is a positive integer. The choice of m follows below, since scaling functions
(instead of wavelets), as the span of the set of scaling functions at a given level j, are the same
as that of the sum of ϕ(t) and the wavelets at levels 0, 1,…, j-1. Moreover, if scaling functions
ϕ j ,k (t)are used to approximate some function h(t), and both ϕ and h have at least ν derivatives,
then the mean squared error in the approximation is bounded by C2−νj, where C is some
positive constant, (see, for example reference [44]).
To approximate ψ j0,kr (t) for some fixed j0, we simply compute y j0,0r (t) using the pyramid
algorithm [45], then take the DWT and set the coefficients em0,l  to be equal to the scaling function
coefficients em0,k  at level m0, where m0 = j0 + m. Recall that the wavelets at level j are simply shifts
of each other y j ,k (t)= y j ,0(t −2− jk ),  hence
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Figure 8. Wavelet Probability Bands (WPB 90%’s) (thin lines) with simulated infusion profile (thick line) for Patients 8,
25 (P8, P25: good trackers, LHS) and Patients 9, 34 (P9, P34: poor trackers, RHS).
As we are assuming periodic boundary conditions, the em0,l  can be cycled periodically. Given
the localised nature of wavelets, the coefficients em0+1,l  employed to approximate ψ j0−1,0r (t) can
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The approximation in Equation (15) cannot be employed for wavelets at the m finest levels
J −m, ..., J −1. These wavelets are however, written in terms of both scaling functions and
wavelets at the finest level of detail, level J-1, via the block-shifting method as delineated above.
From Equation (11) we have that f i | y  is the convolution of the posteriors of the wavelet
coefficients and the scaling coefficient given by,
( ) ( )0,0 0,0 , , ,| | |  .                i j k j k j k i
j k
f c c t d d tf yé ù é ù¢¢ ¢¢= +é ùë û ë û ë ûååy (18)
Density Estimation and Wavelet Thresholding via Bayesian Methods: A Wavelet Probability Band and Related…
http://dx.doi.org/10.5772/52434
139
If X and Y are independent random variables and a and b are real constants, then
( ) ( )( )
1 ,  1
 ,  2,3,r r r
a X b raX b a X r
kk k
ì + =ï+ = í =ïî L
(19)
and we have by the additivity property
( ) ( ) ( ) ,  .r r rX Y X Y rk k k+ = + Î¢ (20)
for all r. Applying Equations (19) and (20) to Equation (17) shows f i | y  (where f i = f (xi)) can
be estimated from its cumulants as
( ) ( ) ( ) ( ) ( )0,0 0,0 , , , ,| | |  .    r rr i r j k i r j k j k j k i
j k
f c c t d d tk k f k y¢¢ ¢¢= +ååy (21)
The first cumulant κ1(y),  is the mean of y, the second cumulant, κ2(y),  is the variance of y,
κ3(y) / κ23/2(y) is the skewness, and κ4(y) / κ22(y) + 3 is the kurtosis. Note that the third cumulant
κ3(y) and the fourth cumulant κ4(y) are zero if y is Gaussian. From Equations (16) and (21),
we can now re-write the fourth cumulant as follows,
( ) ( ) ( ) ( ) ( )
( ) ( ) ( ) ( )
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for κr(y) the rth cumulant of y, and for suitable coefficients, ρ j ,k  acquired via the IDWT
algorithm which incorporates scaling function coefficients to assess this sum [41, 42, 46].
Bayesian wavelet regression estimates have thus been developed including priors on the
wavelet coefficients d j ,k ,  which are updated by the observed coefficients d ″ j ,k  to obtain
posterior distributions d j ,k | j ,k  (refer to Equation (18)). The d˜ j ,k  (point estimates) can then be
computed from such posterior distributions and the Inverse Discrete Wavelet Transform
(IDWT) used to estimate f (xi).
The Bayesian wavelet shrinkage rules discussed in this section have used mixture distributions
as priors on the coefficients to model a small proportion of the coefficients which contain
substantial signal [41]. Indeed the BayesThresh method of [41] assumes independent priors on
the coefficients,
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where 0≤γj ≤1.0,  δ(0) is a point mass at zero and d j ,k  are independent. The hyper-parameters
are assumed to be of the form τj2 =C12−αj, γj =min(1, C22−βj) for non-negative constants C1 and
C2 chosen empirically from the data and the α and β’s are selected by the user. The choice of α
and β corresponds to choosing priors in certain Besov spaces [41] and incorporating prior
knowledge about the smoothness of f (xi) into the prior. See reference [55].
4.2. New Bayesian 90% wavelet probability band metric for tracking (WPB 90%)
Bayesian wavelet shrinkage methods as discussed in section 4.1 can be used to create a wave‐
let probability band (WPB). A 90% wavelet probability band (WPB 90%) is constructed for each
of the 37 patient profiles, and the time and duration of any significant deviations from the wavelet
probability band is recorded. A WPB 90% value of 70% implies that for at least 70% of the time
(of the time in ICU observation), the estimated mean value of the recorded infusion rate for a
given patient lies within its 90% confidence interval of its wavelet probability band. Figure 8
shows the WPB for 4 patients: two good trackers (Patients 8 and 25) and two poor trackers (Patients
9 and 34). The circle symbol represents the hourly recorded infusion rate, the thin line repre‐
sents the 90% WPB curve and the solid thick line represents the simulated profile (Figure 8). Brief
spikes which may occur in the WPB bands are typical of wavelet regression methods. These
spikes can be smoothed out by using different values for α and β, but this risks over-smooth‐
ing the data due to loss of information. According to [41], setting α=0.5 and β=1 is the best practical
approach for Bayesian smoothing. Therefore we set α=0.5 and β=1 and employ Daubeches’ least
asymmetric wavelet with eight vanishing moments, namely LaDaub (8), as this is a widely used
wavelet and is applicable to a broad variety of data types.
While our WPB approach is graphically very useful (Figure 8), it is however useful to marry
this with an objective numerical measure of how close the simulated infusion profile is to the
empirical, recorded data. The percentage WPB cannot serve this purpose of objective quanti‐
fication, because it quantifies visual proximity, by means of artificial hard boundaries, and
ignores the fact that the in-band region does not have the same probabilistic significance
everywhere. Thus wavelet density numerical metrics, namely ANWD and RANWD, compar‐
ing the model outputs to the recorded data were also developed using the posterior densities
determined from the smoothed recorded data. The density profile is considered to be infor‐
mative as unlike the wavelet probability band (WPB) it does discriminate between regions of
high or low probability within a band.
5. WTCI based results
5.1. Choice of Wavelet filter and Bootstrap: WTCI
In order to judge the reliability of the wavelet time coverage index (WTCI) for a given patient’s
infusion profile, the moving blocks bootstrap was utilized [56]. A total of 1000 bootstrap
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realizations were generated for each patient’s recorded infusion profiles.  A wavelet time
coverage index (WTCI), as defined in Equation (12), can then be evaluated for each boot‐
strap realization, providing a collection of 1000 values of the WTCI. The median WTCI and
its standard error, SE, can then be reported for each patient using [57] (see Table 1, where a
bold Patient no. indicates a poor tracker by the DWT, WCORR and WCCORR diagnostics in
[29]). When the DWT is implemented via the pyramid algorithm [58], an important feature
when analysing a given time, is the need to choose the appropriate wavelet filter (basis). The
choice of a wavelet basis function is crucial for two reasons. First,  the length of a DWT
determines how well it approximates an ideal band-pass filter, which in turn dictates how
well the filter is able to isolate features to specific frequency intervals. Secondly, as illustrat‐
ed in the MODWT MRAs shown in [29], the wavelet basis function is being used to represent
information contained in the time series of interest and should thus imitate its underlying
features. A reasonable overall strategy is to use the shortest width of wavelet filters L= 4, 8
and longer wavelet filters L = 10, 12, as both choices give reasonable results in this ICU A-
S application.





1 3601 78.55 0.538
2 6421 87.14 0.294
3 6541 87.85 0.106
4 4921 87.94 0.076
5 2941 88.89 0.103
6 5701 88.73 0.104
7 3901 84.78 0.324
8 10561 93.61 0.037
9 8581 93.28 0.046
10 20701 88.46 0.053
11 6721 92.46 0.085
12 8521 91.15 0.323
13 5161 91.37 0.091
14 3001 82.09 0.449
15 4981 92.09 0.072
16 13621 94.57 0.073
17 5941 90.27 0.086
18 4681 93.83 0.036
19 7921 96.34 0.012
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20 9661 90.49 0.088
21 3721 83.07 0.685
22 9661 91.85 0.056
23 3481 85.07 0.300
24 8461 92.41 0.058
25 3841 93.44 0.082
26 3901 85.49 0.275
27 13441 93.66 0.039
28 12241 89.47 0.051
29 3241 89.3 0.262
30 3661 85.81 0.092
31 18301 94.34 0.022
32 15181 95.82 0.020
33 25261 95.63 0.036
34 8101 93.77 0.070
35 12721 87.64 0.018
36 3481 92.17 0.059
37 7501 90.79 0.079
Median 90.790 0.079
95%CI (88.75, 92.39) (0.058, 0.092)
Table 1. Wavelet Time Coverage Index (WTCI) per patient. Data size (column 2) indicates the length of the patient’s A-
S series. A bolded /shaded Patient indicates a poor tracker by the criteria in [29].
Table 1 presents the data size (time series length) and median bootstrapped WTCI and its
standard error (SE) for each of the 37 patients studied. The poor trackers, as classified by the
criteria in [29], are bolded in the first column. From Table 1, we note that some poor trackers
(Patients 9, 11, 22, 27, 32, 34) have relatively high values of median WTCI and some good
trackers (Patients 1, 14) have a low WTCI. The reason for this is padding, used as a reasonable
solution to produce data of the size power of two, but this dilutes the signal near the end of
the original data set, since the filters are not applied evenly. Hence multiplying by a signal
element, constrained to have magnitude zero, is equivalent to omitting the filter coefficient,
and then the orthogonality of the transform is not strictly maintained. To overcome this
problem we change the current minutes driven length of the A-S data set to an hourly meta-
meter, and then apply Bayesian wavelet shrinkage using a universal threshold as developed
in section 5.2.
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5.2. Alternative WTCI measure via Bayesian Wavelet Thresholding
In Section 5.1 the minimax estimator [59] was used to obtain patient specific WTCI measures
(see also section 4.1). In this section we calculate an alternative WTCI using Bayesian wavelet
thresholding [53, 44, 50, 41, 42]. Table 2 reports the WTCI measures, which are obtained by
employing a Bayesian wavelet thresholding as computed by the WaveThresh software
package in R [42] (adopting a LaDaub (8) filter).
The relative total dose, defined as the total drug dose delivered by the simulation (as a
percentage of the total recorded drug dose) is also presented for each patient in Table 2. From
Table 2 high values of median WTCI clearly indicate the validity of the A-S simulation for a
given patient. The median WTCI value (across all patients) is 79.8% with a 95% interpolated
confidence interval (CI) of (77.57%, 83.23%) and a range [71.9% to 88.9%]. This indicates some
significant merit of the mathematical model of [14] and its physiological validity (Table 2).
Furthermore, the overall patient median relative total dose is 89.1% with a range [77.0% to
95.0%] indicating that the simulated and recorded total drug doses are similar, with the
simulator consistently administering slightly less than 100% of the recorded actual sedative
dose (Table 2). Slightly decreased levels as such are linked with the sudden-response nature
of the recorded infusion profiles, in contrast to the consistent, smooth quality of the simulated
infusion. These features are chiefly the result of the consistency of the computer implemented
simulation in contrast to the inherent variation between different nurses’ assessment of patient
agitation and appropriate feedback of sedation [14, 11, 12, 13].
Overall from Table 2 the values of the WTCI from the bootstrap realizations (per patient) have
high median WTCI and a low spread per patient, indicating high reliability of the median
WTCI and in turn of the A-S simulation. Larger spread indicates poor reliability, which may
be caused by insufficient data, and also by the choice of wavelet filters, the chosen thresholding
method, or by the model simulation method itself.
Patient no. Median WTCI SE Relative total Dose (%)
1 74.0 0.378 87.8
2 77.4 0.461 85.9
3 76.6 0.264 86.1
4 79.2 0.650 86.6
5 79.3 0.324 90.3
6 84.6 0.697 87.5
7 75.5 0.083 81.0
8 84.3 0.381 92.1
9 88.1 0.359 89.1
10 74.9 0.175 90.2
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Patient no. Median WTCI SE Relative total Dose (%)
11 72.0 0.395 87.8
12 83.8 0.261 86.5
13 82.8 0.166 90.2
14 76.6 0.248 88.5
15 86.3 0.145 90.7
16 84.8 0.431 90.4
17 83.3 0.430 85.2
18 84.2 0.161 95.0
19 86.5 0.341 91.0
20 80.5 0.303 90.4
21 72.1 0.498 87.8
22 77.5 0.171 89.5
23 79.8 0.673 91.7
24 85.1 0.127 89.9
25 88.9 0.075 91.2
26 82.8 0.061 88.5
27 75.7 0.663 87.5
28 75.0 0.202 90.6
29 73.4 0.442 77.0
30 83.3 0.224 94.5
31 82.6 0.146 90.0
32 82.6 0.271 91.2
33 78.5 0.430 90.4
34 85.9 0.193 89.0
35 74.1 0.361 88.1
36 79.1 0.293 81.6
37 78.6 0.283 88.9
75th percentile 84.3 0.43 90.4
Median 79.8 0.293 89.1
95% CI: Median (77.57, 83.23)
25th percentile 76.14 0.173 87.5
Table 2. Alternative Wavelet Time Coverage Index (WTCI) summary for the 37 patients. A bolded/shaded patient
indicates a poor tracker by the DWT WCORR and WCCORR threshold criteria in [29].
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6. Bayesian WPB results
6.1. Wavelet probability band metric for tracking (WPB 90%)
Table 3 presents the time per patient that the simulated infusion rate lies within the 90%
wavelet probability band (WPB 90%). Generally high values of WPB 90% are evident across
most of the 37 patients (second column of Table 3). With the exception of thirteen (13) patients
(Patients 2, 4, 7, 9, 10, 11, 21, 22, 27, 28, 32, 33, 34), all simulated infusion profiles lie within
the wavelet probability band at least 75% of the time. These 13 patients were also all deemed
to be “poor trackers” according to the WCORR and WCCORR diagnostics developed in [29].
The main reason for the reduced total time within the WPB for these 13 poor trackers seems
to be their poor performance throughout the total length of the patient’s simulation. This
feature is observed in Figure 8 for patient 9 and for patient 34, and indicates that the simulated
infusion profile deviates from the recorded profile over some particular period, and takes
some time before tending towards the recorded infusion rate again (see Patients 9 and 34 in
Figure 8).
6.2. Comparison of WPB 90% with WTCI measures
Patients 25 and 34 will now be used to illustrate some of the concepts linking and differentiating
the different wavelet measures in Table 2 and Table 3. Note that Patient 25 has the maximum
WTCI of 88.9% with a high value of relative total dose of 91.2% (Table 2), and patient 25 exhibits
low spread in the bootstrapped realization in Figure 7. Table 3 similarly shows that Patient
25’s simulated infusion rate lies within the 90% WPB for 89.06% of the time, indicative of good
performance (or tracking), as is evident in the WPB plot (Figure 8). By contrast, Patient 34 has
a high WTCI of 85.9%, a relative total dose of 89.0% (Table 2), and exhibits low spread in the
bootstrapped realizations, but by contrast Patient 34 has a very low WPB 90% value of 48.44%
(Table 3 and Figure 8).
Recall from [29] that Patient 25 is deemed to be a good tracker and Patient 34 a poor tracker
by earlier DWT WCORR criteria. Hence whilst the WTCI values of Patient 25 and Patient
34 are both high, 88.9% and 85.9%, respectively; it is only the WPB 90% measure, and not
the WTCI measure, that distinguishes between the tracking performance of Patient 25 (WPB
90% = 89.06%) and Patient 34 (WPB 90% = 48.44%). Patient 34’s simulation infusion rate is
outside the WPB band for 51.56% of the time indicating that a large maximum departure
time between the patient’s recorded and simulated infusion rate occurs in the ICU observa‐
tion period (see [29]).
6.3. Comparison of WPB 90% with ANWD and RANWD measures
The higher the percentage that the simulated infusion profile lies within the wavelet proba‐
bility band, for a given patient, the better the simulation model captures the specific dynamics
of the agitation-sedation system for that patient. Patient-specific WPB 90% values are reported
in Table 3. Columns 3 and 4 in Table 3 present the two novel and alternative performance
measures of ANWD and RANWD per patient. Recall that the posterior distribution of the
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regression curve is used as the density for all patients as described in reference [14]. RANWD
thus measures how probabilistically similar the model outputs are to the smoothed observed
data, and hence is a measure of the degree of comparability between the simulated and the
empirical A-S data. The density profile is used to compute the numerical measures of ANWD
and RANWD, so that objective comparisons of model performance can be made across
different patients. The ANWD value for the simulated infusion rates is the average of these
normalized density values over all time points for a given patient. Similarly, the RANWD value
for the smoothed infusion rate is obtained by superimposing the smoothed values by using
the first cumulant from a normal posterior distribution onto the same density profile, after
which RANWD can be readily computed.
Patient no. WPB 90% ANWD RANWD
1 95.31 0.537 0.553
2 64.06 0.431 0.499
3 96.88 0.632 0.737
4 59.38 0.338 0.475
5 93.75 0.495 0.504
6 95.31 0.659 0.980
7 67.19 0.417 0.455
8 87.50 0.567 0.688
9 57.81 0.343 0.412
10 66.80 0.300 0.388
11 74.34 0.423 0.434
12 84.38 0.622 0.662
13 73.44 0.442 0.504
14 96.88 0.449 0.476
15 89.06 0.702 0.761
16 82.81 0.596 0.770
17 85.94 0.506 0.566
18 93.75 0.548 0.558
19 74.22 0.759 0.780
20 96.88 0.487 0.581
21 65.62 0.407 0.413
22 65.62 0.422 0.455
23 92.19 0.288 0.341
24 71.00 0.655 0.635
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Patient no. WPB 90% ANWD RANWD
25 89.06 0.635 0.670
26 96.88 0.600 0.601
27 47.27 0.368 0.608
28 50.78 0.501 0.540
29 82.81 0.343 0.394
30 96.88 0.554 0.597
31 87.50 0.562 0.669
32 68.36 0.326 0.362
33 58.79 0.373 0.499
34 48.44 0.505 0.551
35 96.10 0.371 0.533
36 75.00 0.573 0.763
37 79.69 0.448 0.607
Min 47.27 0.288 0.341
Median 82.81 0.495 0.552
Max 96.88 0.759 0.981
Table 3. Wavelet probability band (WPB 90%), ANWD and RANWD measures per patient. A bold patient no. indicates
a poor tracker by the RANWD and WPB criteria (developed in section 6.4). (The 13 poor trackers are P2, P4, P7, P9, P10,
P11, P21, P22, P27, P28, P32, P33 and P34).
An overall median RANWD of 0.552 (Table 3) with range [0.341 to 0.981] is an objective
measure that supports the WPB 90% measures and visual clue of closeness based on the WPB
(see Figure 8). It should be noted that as the model is deterministic, its outputs do not belong
to the same probabilistic mechanism that generated the data, hence RANWD is an extremely
stringent measure.
6.4. WPB 90% and RANWD criteria for poor tracking
Given the conservative nature of the RANWD metric, consistently high RANWD values close
to 1.00 are not expected, even for a good simulation model. A reasonable and practical
threshold for adequate model performance is RANWD ≥ 0.5, which suggests that the model
outputs are more alike than not to the smoothed data. Justification for our 0.5 threshold for
RANWD is given in this section, as is a threshold for WPB 90%. Poor trackers according to the
metrics developed in this chapter are assumed to satisfy the following:
RANWD≤0.5 and/or a WPB 90% ≤70%.
Thirteen (13) patients have a low RANWD (deemed below the threshold, RANWD ≤ 0.50),
namely Patients 2, 4, 7, 9, 10, 11, 14, 21, 22, 23, 29, 32 and 33 (Table 4). Specifically 9 of these
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patients have RANWD values from 0.412 to 0.499, and 4 have RANWD values between 0.341
and 0.394. Furthermore 11 patients have a WPB 90% value less or equal to 70% (Patients 2, 4,
7, 9, 10, 11, 27, 28, 32, 33, 34). Whilst Patients 14 and 23 have low RANWD values they exhibit
very high WPB 90% (> 92%) values (like P29) (Table 3). Note that these 3 patients (P14, P23,
P29) were also classified as good trackers according to the criteria developed earlier in [13],
[14] and [29]; and as such, given their high WPB 90%, values, will be classified as good trackers
in this chapter. Clearly the WBP 90% measure can help find patients (good trackers, say) who
have elevated percentage time in the WPB ( (range 83% - 97%) for these 3 patients (P14, P23,
P29) even though they exhibit relatively low RANWD values (range 0.34-0.47) (see column 3
Table 6).
Thirteen patients which satisfy our criterion for poor tracking (RANWD ≤ 0.5, and/or a WPB
90% ≤  70%) are P2, P4, P7, P9, P10, P11, P21, P22, P27, P28, P32, P33 and P34 - all of whom,
were also identified as poor trackers by the WCORR and WCCORR DWT diagnostics of
[29]. Of these 13 poor trackers 8 have both lower than threshold WPB 90% and low RANWD,
3 exhibit low WPB 90% but above threshold RANWD > 0.5, and 2 exhibit low RANWD
but above threshold WPB 90% (see Table 6).  This indicates a significant and high agree‐
ment  between  the  WPB  and  the  RANWD  (dichotomized)  criteria  (kappa  =  0.6679);  P
(estimated kappa ≤ 0.40) = 0.025).
The resultant, RANWD and WPB 90% thresholds also provide very strong support for the
DWT wavelet diagnostics derived in reference [29], in that of the 15 DWT based poor trackers
identified in [29] (see Table 6), 13 of these also exhibit a low WPB (WPB 90% < 70%) and/or a
low wavelet density based RANWD (RANWD ≤ 0.5). Statistically speaking the wavelet
probability band and density diagnostics developed in this chapter mirror the DWT based
poor versus good classification of [29] (kappa = 0.87, p = 0.0001).
Our 13 poor trackers have WPB and density profiles (not all reported here) which have specific
regions where the patient’s DE model did not appear to capture the observed A-S dynamics.
In some scenarios, this may occur in the absence of a stimulus or when low drug concentrations
coincide with an agitation level that is decreasing (but not close to zero), thus causing the
patient’s agitation to remain at a constant non-zero level, despite their recorded infusion rate
dropping to near zero.
6.5. Comparison of WPB 90% with Rudge’s physiological model [13] (AND, RAND
measures)
The non-wavelets based and earlier performance metrics of AND and of RAND per patient
are also given in Table 4. Table 4 thus provides a comparison between the WPB 90%, ANWD
and RANWD and TIB, AND and RAND measures from Rudge’s Physiological Model [12,
13]. A highlighted patient is a poor tracker by the WCORR/WCCORR criteria in [29]. Table
4 along with Table 3, allows comparison between Rudge’s [13] values of AND and RAND,
with our WPB model diagnostics (WPB) and our wavelet-based estimates of ANWD and
RANWD. An underlined patient indicates a poor tracker by our RANWD and WPB criteria
(see also Table 6).
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Patient no. WPB model Rudge’s Physiological Model
WPB 90% ANWD RANWD TIB 90% AND RAND
1 95.31 0.537 0.553 96 0.51 0.62
2 64.06 0.431 0.499 90 0.53 0.66
3 96.88 0.632 0.737 97 0.70 0.83
4 59.38 0.338 0.475 93 0.56 0.62
5 93.75 0.495 0.504 97 0.60 0.80
6 95.31 0.659 0.980 95 0.70 0.84
7 67.19 0.417 0.455 67 0.33 0.43
8 87.50 0.567 0.688 90 0.45 0.59
9 57.81 0.343 0.412 89 0.49 0.62
10 66.80 0.300 0.388 53 0.27 0.34
11 77.34 0.423 0.434 59 0.31 0.38
12 84.38 0.622 0.662 96 0.61 0.77
13 73.44 0.442 0.504 85 0.37 0.45
14 96.88 0.449 0.476 95 0.48 0.56
15 89.06 0.702 0.761 95 0.45 0.60
16 82.81 0.596 0.770 91 0.44 0.57
17 85.94 0.506 0.566 91 0.61 0.72
18 93.75 0.548 0.558 92 0.55 0.68
19 74.22 0.759 0.780 90 0.50 0.66
20 96.88 0.487 0.581 91 0.53 0.65
21 65.62 0.407 0.413 95 0.53 0.72
22 65.62 0.422 0.455 83 0.35 0.45
23 92.19 0.288 0.341 95 0.72 0.85
24 71.10 0.655 0.635 91 0.43 0.54
25 89.06 0.635 0.670 86 0.50 0.66
26 96.88 0.600 0.601 92 0.68 0.88
27 47.27 0.368 0.608 84 0.39 0.49
28 50.78 0.501 0.540 76 0.34 0.44
29 82.81 0.343 0.394 90 0.38 0.45
30 96.88 0.554 0.597 97 0.63 0.82
31 87.50 0.562 0.669 74 0.40 0.51
32 68.36 0.326 0.362 74 0.38 0.50
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Patient no. WPB model Rudge’s Physiological Model
WPB 90% ANWD RANWD TIB 90% AND RAND
33 58.79 0.373 0.499 67 0.28 0.36
34 48.44 0.505 0.551 84 0.43 0.55
35 96.10 0.371 0.533 70 0.38 0.46
36 75.00 0.573 0.763 83 0.52 0.64
37 79.69 0.448 0.607 92 0.53 0.59
Min 47.27 0.288 0.341 53 0.27 0.34
Median 82.81 0.495 0.552 90 0.49 0.60
Table 4. Comparison between the WPB, ANWD and RANWD and TIB, AND and RAND from Rudge’s Physiological Model
[12, 13]. A boxed patient is a poor tracker by the WCORR /WCCORR criteria in [29]. A shaded patient indicates a poor
tracker by our RANWD and WPB criteria (13 patients: P2, P4, P7, P9, P10, P11, P21, P22, P27, P28, P32, P33 and P34).
6.6. Comparison of WPB, WTCI, ANWD and RANWD across poor versus good tracking
groups
Table 5 gives summary statistics of the wavelet density based metrics (WPB, WTCI, ANWD
and RANWD) for the poor versus good trackers (classified using the threshold criterion for
WPB 90% ≤  70% and RANWD≤ 0.50). The poor trackers have significantly lower median
values of WPB 90% (64.84% versus 87.50%) (p ≤ 0.001); a significantly lower median value of
WTCI (76.56% versus 82.79%) (p ≤ 0.041); a significantly lower median value of ANWD (0.41
versus 0.55) (p ≤ 0.001) and a significantly lower median value for RANWD (0.46 versus 0.59)
(p ≤ 0.001) compared to the good tracking group.
WPB 90% WTCI ANWD RANWD
Poor trackers
Min 47.27 71.95 0.03 0.36
Max 77.34 88.05 0.50 0.61
Range 30.07 16.01 0.21 0.25
Mean 61.56 77.97 0.39 0.47
95% CI of Mean (65.79, 67.32) (74.72, 81.22) (0.36, 0.44) (0.42, 0.51)
Median 64.84 76.56 0.41 0.46
95% CI of Median (52.63, 67.09) (74.89, 81.69) (0.34, 0.43) (0.41, 0.53)
Good trackers
Min 58.79 73.37 0.29 0.34
Max 96.88 88.94 0.76 0.98
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WPB 90% WTCI ANWD RANWD
Range 38.09 15.57 0.47 0.64
Mean 85.31 81.36 0.53 0.60
95% CI of Mean (80.85, 89.77) (76.62, 83.09) (0.48, 0.57) (0.55, 0.66)
Median 87.50 82.79 0.55 0.59




0.001 0.041 0.001 0.001
Table 5. Summary of the wavelet based performance metrics: poor versus good trackers.
6.7. Poor trackers compared across 3 studies (references [29], [14] and [13])
Table 6 summarises the patient numbers of the poor trackers according to the criteria of four
studies, including the research described in this chapter (i.e. Kang’s WPB diagnostics, see column
1). The four studies reported across columns 1, 4-6 in Table 6 are Kang’s WPB, WCORR diagnostics








Chase et al. [14]
diagnostics
Rudge el al. [13]
diagnostics
- - - -
2 2 2 2 - -
- - - - - -
4 4 4 4 - -
- - - - - -
- - - - 6 -
7 7 7 7 7 7
- - - - - -
9 9 9 9 9 -
10 10 10 10 - 10
11 11 11 11 - 11
- - - - 12 -
- - - - - 13








Chase et al. [14]
diagnostics
Rudge el al. [13]
diagnostics
14Φ - - -
- - - - - -
- - - - - -
- - - - 17 -
- - - - - -
- - - - - -
- - - - - -
21 21 21 21 -
22 - 22 22 - 22
23Φ - - -
- - - - - -
- - - - - -
- - - - - -
27 27 27 27 27
28 28 28 - 28
- - 29Φ 29 - 29
- - - - - -
- - - - - -
32 32 32 32 - -
33 33 33 33 - 33
34 34 - 34 34 -
- - - 35 - 35
- - - - - -
- - - - - -
Total: N1= 13 Total: N2=15 Total: N3=8 Total: N4=10
Table 6. Patient numbers of the poor trackers according to the criteria of 4 studies. Φ P14 and P23 have low RANWD
values but high WPB 90% (> 92%) (like P29). P14, P23, P29 were classified as good trackers according to the criteria
developed earlier in [13], [14] and [29], and as such, and given their high WPB 90%, are classified as good trackers by
our Kang WPB diagnostics.
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The resultant ANWD, RANWD, WTCI and WPB 90% thresholds also provide very strong
support for the DWT wavelet diagnostics derived in reference [29], in that of the 15 DWT based
poor trackers identified in [29], 13 also exhibit a low WPB (WPB 90% < 70%) and/or a low
wavelet density based RANWD measure (RANWD ≤ 0.5), and are likewise deemed to be poor
trackers (Table 6). Statistically speaking the wavelet probability band and density diagnostics
developed in this chapter mirror the DWT based criterion of [29] (kappa = 0.87, p = 0.0001).
Indeed of the 13 patients assessed by our WPB and RANWD criteria to be poor trackers, all
were likewise judged to be poor trackers by the earlier DWT WCORR and WCCORR criteria
developed in reference [29] (see Table 6 and also see Tables 4-5 of [29]). This indicates perfect
agreement between the RANWD threshold developed in this chapter and the earlier DWT
WCORR and WCCORR based criteria for poor tracking in [29] (kappa = 1.00, p = 0.0000).
The performance metrics of AND and RAND and their patient specific values are given in
Table 4, which along with Table 3 also allows comparison between Rudge’s [13] (AND and
RAND) values with our WPB model diagnostics (WPB, ANWD, RANWD). Rudge’s Physio‐
logical Model [12, 13] found 10 of the 37 patients (27%) have values of RAND ≤  0.5, with 5
patients with 0.43< RAND<0.49, and 3 with 0.34 < RAND <0.38 (Tables 4 - 5). The model in [63]
likewise found that 27 patients (73%) have RAND values greater than 0.57, with 10 poor
trackers, with 6 RAND values ranging from 0.43 to 0.49, and with 3 patients exhibiting RAND
values between 0.34 and 0.38. The main reason for the reduced total time within the WPB (and
the non-significant WCORRs) for this minority group of 10 - 13 poor trackers (of the total 37
patients), is the consistently poor performance of the DE model throughout their total length
of the A-S simulation. Of the 13 patients assessed by our RANWD and WPB criteria to be poor
trackers, 7 patients (P7, P10, P11, P22, P27, P28, P33) were likewise judged to be poor trackers
by the earlier Physiological Model of Rudge [13] (kappa = 0.30, p = 0.03). This shows significant
agreement between the physiological Model [13] based criteria for poor tracking and the
RANWD and WPB 90% thresholds formulated in this chapter (Table 6).
7. Discussion and conclusions
Agitation management via effective sedation management is an important and fundamen‐
tal activity in the ICU. However, in clinical practice a lack of understanding of the underly‐
ing dynamics,  combined with a lack of  subjective assessment tools,  makes effective and
consistent clinical agitation management difficult [14, 12, 13]. The main goal of ICU seda‐
tion is to control agitation, while preventing over-sedation and over-use of drugs. Current
clinical practice employs subjective agitation and sedation assessment scales, combined with
medical staff experience and intuition, to deliver appropriate sedation. This approach usually
leads  to  the  administration  of  largely  continuous  infusions  which  lack  a  bolus-focused
approach, and commonly results in either over sedation, or insufficient sedation [12, 13].
Several recent studies have emphasised the cost and health-care advantages of drug delivery
protocols based on assessment scales of agitation and sedation. Table 7 gives an overview of
recent  ICU  agitation  studies,  and  provides  a  brief  overview  of  the  equations  used  for
simulations of a patient’s A-S status and also of the methods derived in this chapter (and by
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other studies) with the aim of establishing the validity of the models in reflecting a pa‐
tient’s true A-S status.
In this chapter, we successfully developed a density estimation approach via wavelet
smoothing to assess the validity of deterministic dynamic A-S models. This wavelet density
approach provided graphical assessment and numerical metrics (WTCI and WPB 90%,
ANWD and RANWD) to assess the comparability between the modelled and the recorded
A-S data per patient. Our new wavelet regression diagnostics identified 13 ICU patients (pa‐
tients 2, 4, 7, 9, 10, 11, 21, 22, 27, 28, 32, 33 and 34) (out of 37 analysed) [29], whose simulated
A-S profiles were poor indicators of their true A-S status, the remaining patients tracked ex‐
ceptionally well.
All of these 13 poor trackers were also identified as poor trackers by the DWT measures
derived in [29]. The WTCI and WPB 90% metrics derived in this chapter thus give strong
support for the datawork in [29] and vice versa. Our wavelet regression diagnostics (WTCI,
ANWD, RANWD, and WPB 90%) are thus valid for assessing control, as were the wavelet
DWT, wavelet correlation (WCORR) and cross-correlation (WCCORR) measures derived in
[29]. We have thus successfully assessed the patients A-S by the RANWD cut-point and also
distinguished poor trackers, likewise identified by the DWT criteria of [29]. Ten of our 13 so-
called poor trackers were also identified as poor trackers by either the kernel smoothing,
tracking index and probability band approach of  [14]  and [13],  respectively.  Overall  the
various diagnostics strongly agree and confirm the value of A-S modelling in ICU. Our WPB
method is  also shown to be an excellent  tool  for detecting regions where the simulated
infusion rate performs poorly, thus providing ways to help improve and distil the determin‐
istic A-S model. The main reason for the reduced total time within the WPB for a minority
group, of 13 (of 37) i.e. the poor trackers, is the consistently poor performance of the DE
model throughout the total length of the simulation.
Wavelet modelling in this chapter and the earlier work of Kang [29] thereby demonstrate that
the models of the recent A-S studies of [14, 11, 12, 13, 63] and of [64], are suitable for developing
more advanced optimal infusion controllers. These offer significant clinical potential of
improved agitation management and reduced length of stay in critical care. Further details are
available in the recent PhD dissertation of Kang (circa 2012) [67]. The A-S time series profiles
studied in this chapter are of disparate lengths (with a wide range [3,001 - 25,261] time points
in minutes). Our approach is thus generalisable to any study which investigates the similarity
or closeness of bivariate time series of, say, a large number of units (patients, households) and
of time series of varying lengths and of possibly long length. This chapter demonstrates the
value of wavelets for assessing ICU agitation-sedation deterministic models, and suggests new
wavelet probability band and coverage diagnostics by which to mathematically assess A-S
models. Future work will involve creation of singular spectrum analysis (SSA) based similarity
indices following the development of Hudson and Keatley in [68]; and comparing results with
the wavelet density-based indices developed in this chapter with the DWT metrics in [29] and
in references [69] - [70].
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(this chapter) 
See the schema of the approach developed in this chapter below: 
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 ([41], [42]) 
Wavelet shrinkage 
(threshold)  
( [60], [30], [42]) 
Dvelop a density estimation approach via wavelet smoothing for 
assessing the validity of the deterministic dynamic models (simulated 
profiles) against the empirical / recorded data.  
Construct a wavelet probability band (WPB).  
Provide graphical assessment and   numerical metrics of the 
compatibility between the model and the recorded agitation-sedation 
data. 
Develop performance measures as follows: 
1. Average normalized wavelet density (ANWD).  
2. Relative average normalized wavelet density (RANWD). 
3. Median of the Wavelet Time Coverage Index (WTCI). 
Kang et al. [29] See equations in the Chase et al. [14] and the  row below, and  schema in 
Kang et al. [29]  
 DWT analysis and synthesis equations 
X= [X1, X2,…, XN], N=2J , DWT analysis equation W= X,  W= discrete 
wavelet coefficients, = N x N orthonormal matrix 
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Wavelet  shrinkage 
([60], [30]) 
Develop a wavelet correlation (WCORR) and wavelet cross-correlation 
(WCCORR) approach for assessing the validity of the deterministic 
dynamic models against the empirical agitation-sedation data per 
patient. 
Provide graphical assessment tools and wavelet based numerical metrics 
of  the compatibility between the simulated model and the recorded data 
via the discrete wavelet transform (DWT), partial DWT (PDWT), 
maximal overlap DWT (MODWT) and via Multiresolution analysis 
(MRA). 
Investigate the lag/lead relationship between the simulated and recorded 
infusion series on a scale by scale basis via wavelet cross-correlation 
(WCCORR). 
Develop performance measures as follows: 
1. Modulus of the wavelet correlation at wavelet scale 1,   1. 
2. Count the number (out of 8) of non-significant wavelet correlations at 
scales j  (j = 1,2,…,8). 
3. Median and 95% CI of the first 5 wavelet correlations at scales j   
(j  = 1,2,…,5). 
Test poor versus good tracker groups via the Kruskal Wallis test on 1, 2 
and 3 above.  
Rudge et al. [13]  
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Develop a physiologically representative model that incorporates 
endogenous agitation reduction (EAR). 
Use performance measures as follows: 
1. RTD: relative total dose (RTD) expresses the total dose administered in 
the simulation as a percentage of the actual total recorded dose. 
2. Relative average normalised density (RAND) measures how 
probabilistically similar the model outputs are to the smoothed data, and 
hence the degree of comparability between the model and the empirical 
data. 
3. Percentage time in band (TIB). 
Rudge et al. [11] The agitation-sedation system model: 
Phamarcokinetic model adding patient agitation as a third state variable 
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Tracking Index (TI) 
Develop a control model to capture the essential dynamics of the 
agitation-sedation system. 
Use performance measures as follows: 
1. 
p dU K A K A   for the infusion rate. 
2. Tracking Index (TI): Quantitative parameter to indicate how well the 
simulated infusion rate profile represents the average recorded infusion 
profile over the entire time series. 
Lee et al. [64] 
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inequality for the 
probability band [14] 
Develop a nonparametric approach for assessing the validity of 
deterministic dynamics models against empirical data. 
Use performance measures as follows: 
1. Kernel regression and density estimation to yield visual graphical 
display of  data. 
2. Construct a probability band for the nonparametric regression curve 
and check whether the proposed model lies within the band. 
3. Average normalised density (AND) to measure how well the 
simulated values coincide with the maximum density at every time 
point and relative average normalised density (RAND). 
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Chase et al [14]  The agitation-sedation Phamarcokinetic model adding patient agitation as 
a third state variable 
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Develop a mathematical model to capture the essential dynamics of the 
agitation-sedation system and test for statistical validity using the 
recorded infusion data for the 37 ICU patients. 
Use performance measures as follows: 
1. Kernel smoothing using the uniform kernel.  
2. Tracking Index (TI). 
3. Moving blocks bootstrap to gain an understanding of the reliability of 
the TI for a given patient’s infusion profile 
4. 90% Probability Band - by definition the range within at least 90% of 
the time, the estimated mean value of the recorded infusion rate lies 
within the band.  
 
Cc, Cp and Ce are, respectively, the drug concentrations (mg L−1) in the central, peripheral and effect compartments;, U is
the intravenous infusion rate; Vd, Vc, Vp and Ve, respectively, the volume of distribution, the distribution volumes (L) of
the central, peripheral and effect compartments; A is an agitation index, S is the stimulus invoking agitation; K1–K3 are
parameters relating to drug elimination and transport and Kij the transfer rate (L min−1) from compartment i to
compartment j; KCL the drug clearance (L min−1); KT the effect, and w1 and w2 are relative weighting coefficients of the
stimulus and drug effect, respectively. Time is represented by t, and τ is the variable of integration in the convolution
integral Vc, Vp and Ve, respectively, the distribution volumes (L) of the central, peripheral and effect compartments; U the
intravenous infusion rate (mL min−1); A an agitation index; S the stimulus invoking agitation; Kij the transfer rate (L min
−1) from compartment i to compartment j; KCL the drug clearance (L min−1); KT the effect time constant (min−1); Po and Ps
are the concentrations of morphine and midazolam, respectively (mgmL−1), where terms with superscript ‘o’ relate to
the opioid morphine, and terms with superscript ‘s’ relate to the sedative midazolam. Time is represented by t (min), the
variable of integration, and the terms w1 and w2 are the relative weights of stimulus and cumulative effect, representing
the patient sensitivity. Finally, Ecomb is the combined pharmacodynamic effect of the individual effect site drug
concentrations of morphine and midazolam determined using response surface modeling as defined in [66].
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